Guido Sauter
- Molecular Biology top 0.1%
- Oncology top 0.05%
- Pulmonary and Respiratory Medicine top 0.05%
- Cancer Research top 0.05%
- Surgery top 0.2%
- Co-authors
- Michael J. MihatschRonald SimonLukas BubendorfJuha KononenHolger MochPeter SchramlJ. TorhorstMartina Mirlacher
- Topics
- Prostate Cancer Treatment and Research (120 papers)HER2/EGFR in Cancer Research (80 papers)Cancer Genomics and Diagnostics (74 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Guido Sauter
587 papers receiving 34.3k citations
Hit Papers
Peers
Comparison fields: 5 of 174
- Molecular Biology 17.6k
- Oncology 13.6k
- Pulmonary and Respiratory Medicine 10.0k
- Cancer Research 8.1k
- Surgery 5.2k
Countries citing papers authored by Guido Sauter
This map shows the geographic impact of Guido Sauter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Sauter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Sauter more than expected).
Fields of papers citing papers by Guido Sauter
This network shows the impact of papers produced by Guido Sauter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Sauter. The network helps show where Guido Sauter may publish in the future.
Co-authorship network of co-authors of Guido Sauter
This figure shows the co-authorship network connecting the top 25 collaborators of Guido Sauter. A scholar is included among the top collaborators of Guido Sauter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Sauter. Guido Sauter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 43 | |
| 4 | 12 | |
| 5 | 35 | |
| 6 | 39 | |
| 7 | 24 | |
| 8 | 21 | |
| 9 | 130 | |
| 10 | 39 | |
| 11 | 50 | |
| 12 | 111 | |
| 13 | 52 | |
| 14 | 53 | |
| 15 | 23 | |
| 16 | 137 | |
| 17 | 2 | |
| 18 | [Epigenetic inactivation of the WNT antagonist SFRP1 in breast cancer]. | 7 |
| 19 | 373 | |
| 20 | Heterogeneity of erbB-2 gene amplification in bladder cancer. | 161 |
About Guido Sauter
Guido Sauter is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 600 papers that have together received 35.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (120 papers), HER2/EGFR in Cancer Research (80 papers) and Cancer Genomics and Diagnostics (74 papers). The work is most often cited by research in Cancer Research (8.1k citations), Oncology (13.6k citations) and Pulmonary and Respiratory Medicine (10.0k citations). Guido Sauter has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Michael J. Mihatsch, Ronald Simon, Lukas Bubendorf, Juha Kononen, Holger Moch, Peter Schraml, J. Torhorst, Martina Mirlacher, Olli Kallioniemi and Thomas C. Gasser. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.